Transitioning from Vortioxetine to Vilazodone

Monitoring and Safety Considerations

• Watch for withdrawal symptoms including anxiety, insomnia, irritability, dizziness, and nausea during the tapering process 1
• Most antidepressants require 10-14 days of gradual discontinuation to limit withdrawal symptoms, though vortioxetine's label allows for more flexibility 2
• The risk of serotonin syndrome during this transition is low, as both medications enhance serotonergic activity but through slightly different mechanisms 1
• Monitor for confusion, agitation, muscle rigidity, hyperthermia, tremor, and autonomic instability during the transition period 1
• Distinguish between antidepressant discontinuation syndrome (typically peaks within 1-2 weeks and resolves) and true depressive relapse 1
• Monitor for vortioxetine withdrawal symptoms (anxiety, dizziness, irritability) and vilazodone tolerability (nausea, diarrhea) 1
• Assess for adequate symptom control, emergence of side effects, and any signs of serotonin syndrome 1